Postdocs
Christopher Chamberlain
Deciphering T-cell reactivity and regulation in glioblastoma to improve immunotherapy
Postdoc
Herlev Hospital
Christopher Chamberlain, Department of Haematology, University College London, has been awarded a postdoc research grant from the Lundbeck Foundation worth DKK 2.400.000
The project focuses on glioblastoma, the most common and aggressive form of brain cancer in adults. Using tumour samples from patients, he will investigate how immune cells recognise and fight this specific cancer and how these responses are regulated in the tumour. Through this understanding he aims to identify potential new treatment targets.
